This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
Congressional Daily Record
This section is a tribute, commemoration, or district-facing statement.
Issued
September 28, 2026
senate side of the record
People
0
No members linked from this section
Legislation
0
No linked legislation in this section
Committees
0
No linked committees in this section
Senate Holds
0
No hold activity linked here
Source Document
Connected Data
This section does not yet have linked people, bills, or committees in the reader view.
Source Control
Reader mode is for comprehension. The linked government PDF is the official published source.
Download official Senate Record PDFReturn to issue contextSENATE RESOLUTION 914—DESIGNATING SEPTEMBER 2026 AS “NATIONAL
CHOLESTEROL EDUCATION MONTH” AND SEPTEMBER 30, 2026, AS “LDL-C
AWARENESS DAY”
Mrs. HYDE-SMITH (for herself, Mr. Peters, Mrs. Britt, and Mr. Padilla) submitted the following resolution; which was considered and agreed to:
S. Res. 914
Whereas cardiovascular disease is the leading cause of
death for men and women in the United States;
Whereas more than 184,000,000 people in the United States
are projected to have some type of cardiovascular disease by
2050, and total cardiovascular disease-related costs are
projected to triple to $1,800,000,000,000;
Whereas, compared to urban areas, rural areas in the United
States have higher death rates for cardiovascular disease and
stroke and a 40 percent higher prevalence of cardiovascular
disease;
Whereas risk factors contributing to cardiovascular disease
and poor health outcomes include elevated low-density
lipoprotein cholesterol (referred to in this preamble as
“LDL-C” ), high levels of lipoprotein(a) cholesterol,
hypertension, obesity, low awareness of personal risk
factors, genetics, geographic location, and disparities in
access to care;
Whereas lipoprotein(a) cholesterol is predominantly
genetically inherited and can build up in the walls of blood
vessels, creating cholesterol deposits, or plaques, and lead
to atherosclerotic cardiovascular disease;
Whereas clinical guidelines recommend that adults in the
United States should have a lipoprotein(a) test at least once
in their lifetime for cardiovascular risk assessment;
Whereas LDL-C is a modifiable risk factor for
cardiovascular disease, and having lower LDL-C is associated
with a reduced risk of atherosclerotic cardiovascular
disease, including heart attack and stroke, which are the
leading causes of cardiovascular-related mortality;
Whereas more than 25.5 percent of adults in the United
States have high LDL-C;
Whereas more than 200 studies with more than 2,000,000
patients have broadly established that elevated LDL-C causes
atherosclerotic cardiovascular disease;
Whereas atherosclerotic cardiovascular disease is the
build-up of cholesterol plaque within the walls of arteries
and includes acute coronary syndrome, peripheral arterial
disease, and events such as heart attacks and strokes;
Whereas the resources needed to bend the curve on
cardiovascular disease exist, yet fewer than 1 in 4 adults
with high-risk atherosclerotic cardiovascular disease in the
United States achieve guideline-recommended LDL-C targets;
Whereas only 33 percent of individuals with atherosclerotic
cardiovascular disease who are taking statins, a guideline
recommended lipid-lowering therapy, actually achieve LDL-C
goals;
Whereas, although clinical guidelines recommend that a
patient hospitalized for heart attack receive an LDL-C test
in the 90 days following discharge from a hospital, only 27
percent of patients receive the test;
Whereas African-American adults are less likely to receive
an LDL-C test in the 90 days following discharge from a
hospital, despite having a higher prevalence of
cardiovascular disease;
Whereas significant gaps in care may lead to subsequent
cardiovascular events;
Whereas Federal agencies seek to improve access to and
quality of care to reduce heart disease, stroke, and death;
and
Whereas September is recognized as National Cholesterol
Education Month to raise awareness of cardiovascular disease
and the importance of individuals knowing their LDL-C number:
Now, therefore, be it
Resolved, That the Senate—
(1) encourages all individuals in the United States to know
their low density lipoprotein cholesterol (referred to in
this resolution as “LDL-C”) number;
(2) designates September 2026 as “National Cholesterol
Education Month”;
(3) designates September 30, 2026, as “LDL- C Awareness
Day”; and
(4) recognizes the urgent need for screening and treating
of elevated LDL-C to reduce the risk of cardiovascular
disease and cardiovascular events, including heart attacks
and strokes.